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2Abstract1
Previous analysis of a Corynebacterium glutamicum ΔmtrAB mutant showed that the MtrAB2
two-component signal transduction system influences the expression of genes involved in cell3
wall metabolism or osmoregulation, but it remained unknown whether this influence is direct or4
indirect. In order to identify the direct target genes of the response regulator MtrA, chromatin5
immunoprecipitation as a genome-wide approach and DNA affinity chromatography as a gene-6
specific approach were performed. The results indicate that mepA and nlpC, both encoding7
putative cell wall peptidases, are directly repressed by MtrA, whereas proP and betP, both8
encoding carriers for compatible solutes, are directly activated by MtrA.9
10
Introduction11
Sensing environmental changes and triggering appropriate responses is often accomplished in12
bacteria by two-component signal transduction systems [1-3]. The gram-positive soil bacterium13
Corynebacterium glutamicum [4] contains genes for 13 two-component systems [5]. Some of14
them are highly conserved not only in other Corynebacterium species, but also in mycobacteria.15
One of those is the MtrAB two-component system, which was first described in the human16
pathogen M. tuberculosis [6]. While attempts to disrupt the mtrA gene in M. tuberculosis H37Rv17
failed, except when a plasmid-encoded intact mtrA copy was present [7], the mtrAB genes of C.18
glutamicum could be deleted [8]. The ΔmtrAB mutant had a pleiotropic phenotype. In glucose19
minimal medium, it showed a similar growth rate as the wild type, but entered the stationary20
phase much earlier due to acidification of the medium. ∆mtrAB cells were elongated, segmented21
and sometimes showed irregular septum formation. The mutant was more sensitive to penicillin,22
vancomycin and lysozyme, but more resistant to ethambutol. The changes in cell morphology and23
antibiotics susceptibility indicated that the MtrAB system might be involved in cell wall24
3metabolism. Using DNA microarrays, dot blots and primer extension studies, genes with an1
altered mRNA level in the mutant were identified. Some of them showed increased expression in2
the mutant, such as mepA encoding a putative secreted metalloprotease and ppmA encoding a3
putative membrane-bound protease modulator, whereas others display decreased expression such4
as betP encoding a betaine uptake carrier and proP encoding a proline uptake carrier. In5
summary, the analysis of the mtrAB mutant indicated that MtrAB is involved in cell wall6
metabolism and in osmoprotection [8]. In this study we analysed whether increased expression of7
mepA or ppmA is responsible for the phenotype of the ΔmtrAB mutant and searched for direct8
target genes of MtrA by chromatin immunoprecipitation and DNA affinity chromatography.9
10
Materials and methods11
Bacterial strains, media, and growth conditions12
Bacterial strains and plasmids used or constructed in the course of this work are listed in Table 1,13
oligonucleotides in supplementary Table S1. C. glutamicum was routinely cultivated aerobically14
in 500-ml shaking flasks with 60 ml medium on a rotary shaker (150 rpm) at 30 °C. Either Luria-15
Bertani (LB) medium [9], CGXII minimal medium [10] or MM1 minimal medium [11] was used.16
CGXII and MM1 medium contained 2 % or 4 % (w/v) glucose as carbon and energy source. For17
strain construction and maintenance, BHIS agar plates (BHI agar (Difco, Detroit, USA) with 0.518
M sorbitol) were used. E. coli DH5α was grown aerobically on a rotary shaker (150 rpm) at 3719
°C in LB medium or on LB agar plates (LB medium with 1.5 % (w/v) agar). If appropriate,20
kanamycin was added to final concentrations of 25 µg/ml (C. glutamicum) or 50 µg/ml (E. coli).21
For DNA affinity chromatography cells were grown in shaking flasks using CGXII medium with22
4 % (w/v) glucose and harvested in the exponential growth phase at an OD600 of 5 to 6.23
24
4General DNA techniques and sequence analyses1
Standard methods like PCR, restriction or ligation were carried out according to Sambrook et al.2
[9]. E. coli was transformed according to Inoue et al. [12]. DNA sequencing was performed with3
a 3100-Avant genetic analyzer (Applied Biosystems, Darmstadt, Germany). Sequencing reactions4
were carried out with the ABI PRISMTM Big Dye Terminator Cycle Sequencing Kit (Applied5
Biosystems).6
7
Mutant and plasmid construction8
Deletion mutants of C. glutamicum were constructed via a two-step homologous recombination9
procedure as described previously [13]. The primers used for this purpose are listed in Table S1.10
The chromosomal deletions were confirmed by PCR with oligonucleotides annealing outside the11
regions used for deletion (see Table S1). The ∆mtrA- and ∆mtrB-mutants were also confirmed by12
Southern blot analysis (for details see [13]) using NcoI-digested (∆mtrA) or NarI-digested13
(∆mtrB) chromosomal DNA and the corresponding digoxigenin-labelled crossover-PCR product14
as probe.15
16
Antibiotics susceptibility tests17
Quantitative determination of antibiotics susceptibility was performed with Etest® stripes (AB18
Biodisk, Solna, Sweden) as described previously [8].19
20
ChIP-to-chip analysis21
Cultures of the wild type and the ΔmtrA mutant were first cultivated overnight in CGXII minimal22
medium containing 4 % (w/v) glucose. Cells from these precultures were washed in 0.9 % (w/v)23
NaCl solution and used for inoculation of CGXII minimal medium containing 2 % (w/v) glucose.24
5At an OD600 of 5 – 6, cells from 300 ml culture were harvested by centrifugation (10 min, 11,3251
g, 4 °C) and washed in 50 ml CGXII medium without MOPS. Subsequently, the cells were2
resuspended in 10 ml MOPS-free CGXII medium that was supplemented with 1 % (v/v)3
formaldehyde. After incubation for 20 min at room temperature, glycine was added to a final4
concentration of 125 mM and the cultures were incubated for another five minutes. Then, cells5
were harvested and washed twice with 50 ml buffer A (100 mM Tris-HCl, 1 mM EDTA, pH 8.0),6
resuspended in 10 ml buffer A containing 1 mM phenylmethylsulfonyl fluoride, 1 mM7
diisopropyl fluorophosphate and 5 mg RNase A and disrupted by five passages at 172 MPa8
through a French pressure cell (SLM Aminco®, Rochester, USA). The chromosomal DNA of the9
lysate was sheared by sonication (2 x 30 s with a Branson sonifier 250 using a puls length of 4010
% and an intensity of 1) to give an average fragment size of 200 to 1,500 bp. Cell debris was11
removed by centrifugation at 5,300 g for 20 min at 4 °C and the supernatant was used for12
immunoprecipitation. MtrA protein and MtrA-DNA complexes in the supernatant were13
immunoprecipitated for 2 h at 4 °C using 400 µl affinity-purified polyclonal rabbit antibodies14
raised against purified histidine-tagged MtrA protein followed by incubation with 800 µl of 50 %15
protein A-agarose slurry (Pierce, Rockford, USA.) for one hour at 4 °C. The slurry was washed16
two times with 10 ml buffer B (50 mM HEPES pH 7.5, 150 mM NaCl, 1 % (v/v) Triton X-100,17
0.1 % (w/v) sodium deoxycholate), two times with 10 ml buffer C (buffer B with 400 mM NaCl),18
two times with 10 ml buffer D (10 mM Tris-HCl pH 8.0, 250 mM LiCl, 0.5 % (v/v) NP-40, 0.519
% sodium deoxycholate, 1 mM EDTA) and two times with 10 ml buffer A. The slurry was20
resuspended two times in 500 µl elution buffer (50 mM Tris-HCl pH 8.0, 10 mM EDTA, 1 %21
(w/v) SDS), incubated for 10 min at 65 °C and centrifuged. The two supernatants were incubated22
overnight at 65 °C to reverse formaldehyde-induced crosslinks and then treated for 3 h at 55 °C23
with proteinase K (400 µg/ml). The DNA was purified by phenol-chloroform extraction,24
6precipitated with ethanol, washed with 70 % (v/v) ethanol, dried and resuspended in 50 µl H2O.1
The DNA of both elution steps was combined. PCR amplification of the co-immunoprecipitated2
DNA was done according to protocols A and B described at3
http://derisilab.ucsf.edu/pdfs/Round_A_B_C.pdf.  Fluorescence labelling was done as described4
at http://derisilab.ucsf.edu/pdfs/GenomicDNALabel_A.pdf. Hybridisation to the C. glutamicum5
whole-genome microarray and array scanning were performed as described [8].6
7
DNA affinity chromatography and immunoblotting8
Enrichment of DNA-binding proteins interacting with the upstream regions of mepA, nlpC, betP,9
proP, NCgl0102-0103, nrdH-nadE, icd, odhA, sucCD and sdhCAB was performed as described10
before [14, 15]. The corresponding regions were amplified using the oligonucleotides11
mepA_promoter_fw/mepA promoter_rv, nlpC_promoter_fw/nlpC promoter_rv, etc. (see Table12
S1). Proteins binding unspecifically were washed off with a buffer containing 0.1 M NaCl and13
specifically bound proteins were subsequently eluted with a buffer containing 2 M NaCl. The14
proteins present in the high-salt eluate were separated on 15% SDS polyacrylamide gels and15
electroblotted onto nitrocellulose membranes (Hybond-C extra, Amersham). The blots were16
incubated with affinity-purified rabbit anti-MtrA antibodies in a 1:10,000 dilution and17
subsequently with anti-rabbit-IgG-alkaline phosphatase conjugate in a 1:3,000 dilution.18
Immunoreactive proteins were detected by chemiluminescence using the CDP-Star reagent19
according to the instructions of the manufacturer (Roche Diagnostics, Mannheim, Germany).20
21
Results and discussion22
Phenotypic characterisation of mutant strains23
7Analysis of global gene expression of the C. glutamicum ΔmtrAB mutant had indicated that three1
genes showed a more than threefold increased mRNA level compared to the wild type: mepA2
encoding a secreted metallopeptidase, ppmA encoding a putative membrane-bound protease3
modulator and lpqB encoding a lipoprotein of unknown function [8]. The lpqB gene is located4
immediately downstream of mtrB and presumably co-transcribed [8]. If increased expression of5
one of these genes is responsible for the altered cell morphology and antibiotics susceptibility of6
the ΔmtrAB mutant, a deletion of that gene might abolish the phenotype. Therefore, the mutant7
strains ΔmtrABΔmepA and ΔmtrABΔppmA were constructed. All attempts to obtain the deletion8
mutant ΔmtrAB-lpqB were not successfull. We tried both a deletion of the lpqB gene in the9
ΔmtrAB background and a deletion of the entire mtrAB-lpqB gene cluster in the wild-type10
background. The failure to delete lpqB might be a hint at an essential function of this gene.11
Consistent with the fact that a mtrAB deletion mutant could be obtained, it was also possible to12
delete each of these genes separately, resulting in strains ΔmtrA and ΔmtrB.13
The triple mutants ΔmtrABΔmepA (Fig. 1A) and ΔmtrABΔppmA (data not shown) exhibited14
the same growth behaviour in CGXII minimal medium with 4% (w/v) glucose as the ΔmtrAB15
mutant, characterized by a wildtype-like growth rate in the exponential phase and an early growth16
arrest due to a strong acidification of the medium. The cell length was slightly reduced compared17
to the ΔmtrAB mutant and the susceptibility towards penicillin, vancomycin and ethambutol was18
very similar to that strain ΔmtrAB (Table 2). Thus, increased expression of either mepA alone or19
of ppmA alone is not responsible for the pleiotropic phenotype of the ΔmtrAB mutant. In contrast20
to the triple mutants, the ΔmtrA and ΔmtrB single mutants differed in some aspects from the21
ΔmtrAB mutant. Growth of the ΔmtrA strain in CGXII medium with 4% glucose (Fig. 1A) did22
not lead to an acidification of the medium (Fig. 1B) and glucose was consumed completely. After23
8entering stationary phase, a decrease in the optical density of the ΔmtrA culture occurred,1
indicating a partial lysis of the cells. A similar behaviour was observed for the ΔmtrB strain (data2
not shown). The cell length of ΔmtrA and ΔmtrB cells was increased compared to wild-type cells,3
but much shorter than that of ∆mtrAB cells (Table 2). With respect to antibiotics susceptibility,4
the ΔmtrA and ΔmtrB strains resembled the ΔmtrAB mutant with one exception: the ethambutol5
sensitivity of the ΔmtrB mutant was similar to that of the wild type and much lower than that of6
the other mutants (Table 2).7
8
Search for MtrA targets using ChIP-to-chip analysis9
The transcriptome comparison of ΔmtrAB mutant and wild type reported previously [8] allowed10
the identification of genes whose expression is altered as a consequence of the mtrAB deletion,11
but not the distinction whether these genes are directly or indirectly controlled by MtrA. In order12
to identify direct target genes of the response regulator MtrA on a genome-wide scale, chromatin13
immunoprecipitation was combined with DNA chip technology (ChIP-to-chip method). The14
procedure started with in vivo crosslinking of MtrA to its target DNA by treating intact cells with15
formaldehyde and was followed by cell disruption, DNA shearing by sonification and16
immunoprecipitation of the MtrA-DNA complexes with anti-MtrA antibodies. After reversal of17
the crosslinks, the co-precipitated DNA was purified, amplified and labelled with fluorescent18
nucleotides and then hybridized with a whole-genome DNA microarray in order to identify the19
DNA fragments [16, 17]. Here, DNA immunoprecipitated from the wild type was compared to20
DNA immunoprecipitated from the ΔmtrA mutant. The experiment was performed three times21
starting from independent cultures and the results were averaged. The enrichment factor for a22
given gene or genome region was calculated as fluorescence ratio of immunoprecipitated DNA23
from the wild type versus immunoprecipitated DNA of the ΔmtrA mutant. In general, the24
9enrichment factors observed in our experiments were quite low and only three gene regions were1
enriched more than two-fold, namely the promoter region of nlpC (NCgl2108, up to 3.2-fold2
enrichment), the region covering NCgl0102 and NCgl0103 (up to 2.3-fold enrichment), and the3
region between the divergently organized genes nrdH (NCgl2445) and nadE (NCgl2446) (up to4
3.7-fold enrichment). The nlpC gene encodes a secreted protein with an N-terminal signal peptide5
(probable cleavage site behind alanine-35) and a carboxyterminal domain belonging to the6
NlpC/P60 superfamily [18] which might function as cell wall peptidase. The genes NCgl01027
and NCgl0103 encode small membrane proteins of unknown function, nrdH encodes a8
glutaredoxin-like protein that could be involved in electron transport for ribonucleotide reductase9
(the corresponding genes are located nearby), and nadE encodes an NAD+ synthetase.10
Remarkably, only the nlpC gene displayed a more than 2-fold altered (increased) mRNA level in11
the transcriptome comparison of ΔmtrAB mutant vs. wild type (see supplementary data to [8]),12
while the genes located next to the other two enriched regions (NCgl0102-NCgl0103 and nrdH-13
nadE) did not show significantly altered mRNA levels in the microarray experiments. Therefore,14
the relevance of MtrA for the expression of these genes is not yet clear. Most of the genes15
showing altered mRNA ratios in the previous microarray studies showed enrichment factors16
between 1.0 and 1.5 in the ChIP-to-chip experiments, e.g. mepA (1.5), proP (1.0), or betP (1.1),17
not allowing a clear decision on whether they are direct target genes of MtrA. Eventually, the18
procedure used during the initial steps of the ChIP-to-chip experiment has influenced the19
phosphorylation state of MtrA and thereby altered its binding affinity for different target20
promoters.21
22
DNA affinity chromatography with selected promoter regions23
10
As an alternative approach to answer the question whether mepA, proP and betP are direct target1
genes of MtrA, DNA affinity chromatography was performed with the promoter region of these2
genes and C. glutamicum cell extracts. Furthermore, the promoter regions of nlpC, nrdH-nadE3
and NCgl0102-NCgl0103 enriched in the ChIP-to-chip experiments were tested and, as negative4
controls, the promoter regions of icd (isocitrate dehydrogenase), odhA (2-oxoglutarate5
dehydrogenase, E1 subunit), sucCD (succinyl-CoA synthetase) and sdhCAB (succinate6
dehydrogenase). The proteins specifically enriched with the promoter regions were tested for the7
presence of MtrA by Western blot analysis. MtrA was clearly identified in the protein eluates8
with the promoter fragments of mepA, proP, betP, nlpC and nrdH-nadE (Fig. 3). In the high-salt9
eluates obtained with the promoter regions of NCgl0102-NCgl0103 and the negative controls icd,10
odhA, sucCD and sdhCAB, MtrA was not detectable by western blot analysis (Fig. 3).11
12
Target genes of MtrA in C. glutamicum, M. avium and M. tuberculosis13
Combining the results of the transcriptome comparisons of ΔmtrAB mutant and wild type [8], of14
the ChIP-to-chip experiments and of the DNA affinity chromatography studies, at least four15
genes are presumably direct target genes of MtrA in C. glutamicum: mepA, nlpC, betP and proP.16
As the mRNA levels of mepA and nlpC, both encoding putative cell wall peptidases, were17
increased in the ΔmtrAB mutant, MtrA functions as a repressor of these genes. On the other hand,18
the mRNA levels of betP and proP, encoding carriers for compatible solutes, were decreased in19
the ΔmtrAB mutant, indicating that MtrA functions as an activator of these genes. Thus it appears20
that MtrA can function both as an activator and as a repressor. In the case of the promoter region21
of the divergent genes nrdH and nadE both the ChIP-to-chip assay and DNA affinity22
chromatography showed binding of MtrA. However, as the mRNA levels of these two genes23
11
were not significantly altered in the microarray experiments [8], further studies are necessary to1
show an influence of MtrA on the expression of at least one of these genes.2
Recently, an mtrB mutant of Mycobacterium avium was described. It was more sensitive to3
penicillin, ciprofloxacin (gyrase inhibitor) and clarithromycin (inhibits protein biosynthesis),4
showed an increased permeability to the cell-permeating green fluorescent nucleic acid stain5
SYTO16, and exhibited an elongated cell shape [19]. Some of these properties resemble those of6
the C. glutamicum mutants described above. The M. avium mtrB mutant was unable to survive7
intracellularly within THP1 cells and showed decreased expression of a number of genes8
encoding Mce proteins (mce stands for “mammalian cell entry”), which are located on the outer9
surface of mycobacterial cells and have been associated with virulence. Whether these mce genes10
are directly controlled by the MtrAB system is unknown. C. glutamicum, which is a11
nonpathogenic species, does not possess orthologs of the mce genes.12
As indicated before, the mtrA gene of M. tuberculosis was reported to be essential [7].13
Evidence was recently provided that in an MtrA-overproducing strain of M. tuberculosis the14
essential replication gene dnaA could be a direct target of MtrA, since its expression was strongly15
induced [20]. This and several other effects of mtrA overexpression where not observed,16
however, when both mtrA and mtrB were overexpressed. In our transcriptome studies with the17
ΔmtrAB mutant of C. glutamicum, no changes in the mRNA level of dnaA (NCgl0001) compared18
to the wild type were observed [8]. Similarly, the promoter region of dnaA was not enriched in19
the ChIP-to-chip experiments. We cannot exclude of course that dnaA expression is induced in C.20
glutamicum upon overexpression of mtrA.21
The studies performed up to now on the function of MtrAB in C. glutamicum, M. avium and22
M. tuberculosis indicate that this two-component system influences the expression of different23
genes in the different species. However, due to the high similarity in terms of sequence and24
12
genomic organisation of MtrAB, it would be surprising if there are no common target genes and1
the phenotype of the M. avium mtrB mutant supports this view.2
3
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Table 11
Strains and plasmids used in this study2
Strain or plasmid Relevant characteristics Source or
reference
Strains
E. coli DH5α F- φ80dlacΔ(lacZ)M15 Δ(lacZYA-argF) U169
endA1 recA1 hsdR17 (rK- , mK+) deoR thi-1
phoA supE44  λ-  gyrA96 relA1
Invitrogen
(Karlsruhe,
Germany)
C. glutamicum ATCC13032 Biotin-auxotrophic wild-type strain [21]
C. glutamicum ΔmtrAB Derivative of ATCC13032 with an in-frame
deletion of the mtrAB genes
[8]
C. glutamicum ΔmtrABΔmepA Derivative of the ΔmtrAB strain with an
additional in-frame deletion of the mepA gene
This work
C. glutamicum ΔmtrABΔppmA Derivative of the ΔmtrAB strain with an
additional in-frame deletion of the ppmA gene
This work
C. glutamicum ΔmtrA Derivative of ATCC13032 with an in-frame
deletion of the mtrA gene
This work
C. glutamicum ΔmtrB Derivative of ATCC13032 with an in-frame
deletion of the mtrB gene
This work
Plasmids
pK19mobsacB KmR; mobilisable E. coli vector used for
allelic exchange in C. glutamicum (pK18
oriVE.c., sacB,  lacZα)
[22]
17
pK19ΔmepA KmR; pK19mobsacB derivative containing a
crossover PCR product fusing the upstream
and the downstream region of mepA
This work
pK19ΔppmA KmR; pK19mobsacB derivative containing a
crossover PCR product fusing the upstream
and the downstream region of ppmA
This work
pK19ΔlpqB KmR; pK19mobsacB derivative containing a
crossover PCR product fusing the upstream
region of lpqB (in the ∆mtrAB mutant) and the
downstream region of lpqB
This work
pK19ΔmtrΑΒ lpqB KmR; pK19mobsacB derivative containing a
crossover PCR product fusing the upstream
region of mtrA and the downstream region of
lpqB
This work
pK19ΔmtrA KmR; pK19mobsacB derivative containing a
crossover PCR product fusing the upstream
and the downstream region of mtrA
This work
pK19ΔmtrB KmR; pK19mobsacB derivative containing a
crossover PCR product fusing the upstream
and the downstream region of mtrB
This work
18
Table 2
Phenotypic properties of C. glutamicum mutant strains analysed in this work.
Strain
Growth
rate µa
Maximal
OD600a
Cell
lengthb
MICc [µg/ml]
(h-1) (µm) Penicillin Vancomycin Ethambutol
13032 0.40 ± 0.03 59 ± 4 1.5 ± 0.2 0.45 ± 0.07 0.92 ± 0.14 1.7 ± 0.27
∆mtrAB 0.42 ± 0.05 31 ± 4 3.7 ± 0.3 0.15 ± 0.07 0.45 ± 0.19 >256
∆mtrAB∆mepA 0.40 ± 0.01 34 ± 8 2.9 ± 0.8 0.13 ± 0.08 0.55 ± 0.26 >256
∆mtrAB∆ppmA 0.38 ± 0.02 33 ± 8 2.8 ± 0.4 0.17 ± 0.09 0.47 ± 0.06 >256
∆mtrA 0.45 ± 0.06 43 ± 6 2.1 ± 0.6 0.20 ± 0.16 0.53 ± 0.14 >256
∆mtrB 0.44 ± 0.02 40 ± 6 1.8 ± 0.4 0.26 ± 0.07 0.50 ± 0.00 4.33 ± 1.53
a Growth rate and maximal OD600 were determined for at least 3 independent cultivations in
CGXII minimal medium with 4% (w/v) glucose.
b Cell length was determined for cells cultivated in MMI medium.
c Minimal inhibitory concentrations (MICs) were determined with Etest® stripes as described
previously [8]. Mean values and standard deviations were determined from at least three
independent experiments.
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Table 3
PCR fragments used for DNA affinity chromatography
Gene
Position of PCR fragment with respect to
the translation start site
Length of PCR
fragment
mepA -511 to +59 570 bp
nlpC -496 to +52 548 bp
betP -378 to +54 432 bp
proP -506 to +59 565 bp
NCgl0102 -155 to +420 575 bp
NCgl2445 -500 to +50 550 bp
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Figure legends
Fig. 1. Growth (A) and pH changes (B) of C. glutamicum wild type (filled circles) and the
mutants ∆mtrAB∆mepA (open circles) and ∆mtrA (filled triangle) in CGXII minimal medium
with 4 % glucose as sole carbon source.
Fig. 2. Cell morphology of C. glutamicum wild type (A) and the mutants ∆mtrA (B), ∆mtrB
(C),  ∆mtrAB (D), ∆mtrAB∆mepA (E) and ∆mtrAB∆ppmA (F) after overnight growth in MMI
minimal medium with 2 % glucose. Photographs were taken at a 1000-fold magnification
using a Leica microscope DM-LB (Leica Microsystems, Wetzlar, Germany) equipped with
CallCam video camera (Phase, Lübeck, Germany).
Fig. 3. Western blot analysis with affinity-purified anti-MtrA antibodies and the high-salt
eluates obtained by DNA affinity chromatography with the promoter regions of nlpC, betP,
mepA, proP, nrdH-nadE, NCgl0102-0103, icd, odhA, sucCD and sdhCAB.
